Kim hangi aşıyı olmalı? Pfizer Biontech aşısı mı, Çin Coranavac aşısı mı? Aşıların yan etkileri nelerdir?

Koronavirüs hepimizin hayatını çok etkiledi. Şimdiye kadar koronavirüsten çok sayıda kişi hayatını kaybetti. Yeni aşıların bulunmasıyla birlikte içimizde bir umut belirdi. Ülkemizde Biontech aşısının da uygulanmaya başlanmasıyla birlikte özellikle alerjik hastalığı olan kişiler hangi aşıyı seçecekleri konusunda kafa karışıklığı yaşıyor. Aşılara karşı gelişen ciddi alerjik reaksiyon gelişen vakaların bildirilmesi ile birlikte alerjik hastalığı olanlar endişeli. Alerji ve Astım Derneği Başkanı Prof. Dr. Ahmet Akçay alerjisi olanların hangi aşıyı tercih etmesi gerektiği hakkında detaylı bilgi verdi. …

"Kim hangi aşıyı olmalı? Pfizer Biontech aşısı mı, Çin Coranavac aşısı mı? Aşıların yan etkileri nelerdir?"

How many doses will the BioNTech vaccine be made? Who will be given the BioNTech vaccine? Who will not be given the BioNTech vaccine?

04 April 2021 Sunday – 17:11 | Last Updated: 04 04 2021 – 17:11 The Ministry of Health has prepared a guide regarding the BioNTech vaccine that has been introduced. In the guideline, it was stated that the second dose of vaccine will not be administered to those who show allergic reactions in the first dose of vaccine. So, how many doses of BioNTech vaccine will be made? Who will be given the BioNTech vaccine?…

"How many doses will the BioNTech vaccine be made? Who will be given the BioNTech vaccine? Who will not be given the BioNTech vaccine?"

Biontech vaccine journey (from warehouse to hospital) – health news

Vaccines can be kept in vaccine cabinets of 2-8 degrees for 120 hours, ie 5 days. Since Biontech vaccines are mRNA-based vaccines, they are expected to dissolve first, then the vials are diluted with saline. Then, mixing is done by shaking very precisely, after color and particle control is done, it is applied to the citizens in 6 separate doses with disposable syringes from one vial. In cases where it needs to be used quickly,…

"Biontech vaccine journey (from warehouse to hospital) – health news"

First dose of BioNTech vaccine started to be administered – Health News

Pfizer and developed vaccine against Covidien-19 in biontech partnership began to be implemented in Turkey as of today. Following the analysis studies, the vaccine will reach 4.5 million doses in April. In addition, an optional agreement was made with the company for 30 million doses. WHO SHOULD HAVE WHICH VACCINE: BİONTECH OR SİNOVAC?

"First dose of BioNTech vaccine started to be administered – Health News"

Researchers from Stanford University publish “recipe” of Pfizer / BioNTech and Moderna vaccines

Andrew Fire and Massa Shourhem of Stanford University in the US identified the genetic sequence used by both hrm Pfizer and Moderna vaccines and included the mRNA sequences of the vaccines in a post they published last week on the open source site Github. About 56 million developers use Github, a free platform to create, share, and collaborate with each other. BOTTLES OUT OF WASTE ARE COLLECTED The researchers stated that they only collected samples…

"Researchers from Stanford University publish “recipe” of Pfizer / BioNTech and Moderna vaccines"

LAST MINUTE NEWS: BioNTech / Pfizer announces new effectiveness rate: 91.3 percent – Health News

last minute “data-mce-href =” https://www.ntv.com.tr/son-dakika “> Breaking news! The new effectiveness rate of the BioNTech / Pfizer Covid-19 vaccine developed by Turkish Scientist Uğur Şahin and Özlem Türeci has been announced. According to a study conducted on 44,000 people in November, the vaccine’s effectiveness rate was announced as 91.3 percent, while the vaccine was reported to be 100 percent effective in the South African variant called B.1.351. In the statement, it was also stated that…

"LAST MINUTE NEWS: BioNTech / Pfizer announces new effectiveness rate: 91.3 percent – Health News"

Who should get which vaccine?: BioNTech vaccine and Sinovac vaccine prevent serious illness and death

Ankara university (AU) Faculty of Medicine, Head of Infectious Diseases Department. Dr. İsmail Balık, to ensure social immunity Covid-19 He stated that it is vital for the citizens to have the vaccine, which vaccine can be accessed. Fish, “Because, which Vaccine no matter what, it has been clearly shown that vaccines prevent serious illness and deaths. “ Also acting as the President of the Association for Developing Drug Awareness and Rational Drug, Balık made evaluations…

"Who should get which vaccine?: BioNTech vaccine and Sinovac vaccine prevent serious illness and death"

BioNTech / Pfizer started freeze-dried vaccine studies – Health News

Developing the first approved Covid-19 vaccine in the world, BioNTech and its partner Pfizer announced that a freeze-dried version of the Covid-19 vaccine will begin to be tested. It is stated that the clinical trials approved by the US government and companies will be administered to adults between the ages of 18 and 55 in the USA next month, while it is stated that if the vaccine is effective, it can facilitate the storage and…

"BioNTech / Pfizer started freeze-dried vaccine studies – Health News"

LAST MINUTE NEWS: Results of the BioNTech / Pfizer vaccine in children aged 12-15 have been announced – Health News

last minute “data-mce-href =” https://www.ntv.com.tr/son-dakika “> Breaking news! LAST MINUTE NEWS: Pfizer and BioNTech announced on Wednesday that the Covid-19 vaccine resulted in 100 percent safe and effective results in tests with children aged 12 to 15 years, and also produced strong antibody responses. In a statement, the companies said the results paved the way for them to obtain an emergency use permit in the US within a few weeks. Pfizer CEO Albert Bourla said…

"LAST MINUTE NEWS: Results of the BioNTech / Pfizer vaccine in children aged 12-15 have been announced – Health News"

BioNTech Covid-19 increases vaccine production capacity to 2.5 billion doses – Health News

While vaccination studies are continuing within the scope of combating corona virus worldwide, German biotechnology company and corona virus vaccine manufacturer BioNTech updated its vaccine production target. In the statement made by the company, it was announced that after the commissioning of a new facility with the US pharmaceutical giant Pfizer, the Covid-19 vaccine production capacity is expected to be increased to 2.5 billion doses by the end of 2021. “Additional measures and negotiations are…

"BioNTech Covid-19 increases vaccine production capacity to 2.5 billion doses – Health News"